FAQ Part 3: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS)
The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation have announced a $4.2 million grant in support of the MEse...
By: MSSocietyCanada
Read more:
FAQ Part 3: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS) - Video
FAQ Part 1: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS)
The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation have announced a $4.2 million grant in support of the MEse...
By: MSSocietyCanada
Read the rest here:
FAQ Part 1: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS) - Video
How about Stem Cell Therapy for LBD, Nova Cells Institute stem cells
Nova Cells Institute makes a difference because we care - like the Bumble Bee - doing the impossible- http://www.novacellsinstitute.com.
By: NCIM
Follow this link:
How about Stem Cell Therapy for LBD, Nova Cells Institute stem cells - Video
Stem Cell Therapy for Erectile Dysfunction - Alvarado Hospital
The first study in the U.S. to determine if stem cell therapy can treat erectile dysfunction. Alvarado Hospital #39;s Drs. Irwin Goldstein and Barry Handler discuss this FDA-approved study and...
By: AlvaradoHospital
More:
Stem Cell Therapy for Erectile Dysfunction - Alvarado Hospital - Video
Jonathan donating blood stem cells - Feb. 2014
Gift of Life donor Jonathan donated his blood stem cells February 2014 to a patient with Acute Lymphoblastic Leukemia!
By: giftoflifedotorg
See the article here:
Jonathan donating blood stem cells - Feb. 2014 - Video
The Kitchen Sink Salad! Eat Your Natural DHT Blockers and Wake Up Your Stem Cells! Grow Your Hair!
Dee Carter shows you how to create a salad masterpiece! How to eat to grow your hair.
By: RedsKitchen Sink
View original post here:
The Kitchen Sink Salad! Eat Your Natural DHT Blockers and Wake Up Your Stem Cells! Grow Your Hair! - Video
Creation Of Rejuvenated Cell By Stem Cell Therapy - The Line Clinic
Stem cell therapy has become reality which was just possibilities and thoughts of science few days before. This amazing innovation makes life more secured an...
By: Nicky Lee
View post:
Creation Of Rejuvenated Cell By Stem Cell Therapy - The Line Clinic - Video
terapia celular para cinomose - distemper stem cell therapy
Caso de cinomose tratado com terapia celular - unesp - botucatu Stem cell therapy for distemper in a dog.
By: Jean Joaquim
Read more:
terapia celular para cinomose - distemper stem cell therapy - Video
Portland, Oregon and Miami, Fla. (PRWEB) February 10, 2015
Global Stem Cells Group and the Regenerative Technology Alliance (RTA) have signed a memorandum of understanding to evaluate and promote stem cell training programs. RTA, a global provider of standards and certification for the emerging fields of regenerative medicine and science, will work with the Global Stem Cells Group to evaluate the regenerative medicine companys training programs and assess GSCGs participating physicians against the RTAs established international standards for the practice of regenerative and cell-based medicine.
Our new alliance with the RTA is a natural step toward establishing GSCGs recognition as a global leader in stem cell medicine, says Global Stem Cells Group CEO Benito Novas. This is a perfect fit for us, as Global Stem Cells Group shares the RTAs focus on high standards and transparency, especially when it comes to patient safety and advancing the field of stem cell medicine.
We are very pleased to have this alliance, says David Audley, General Secretary and Chair of the RTA. Our goal is to provide the highest level of transparency and oversight for the industry. Working with Global will allow us to have a direct and dramatic impact on physician training.
For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call 305-224-1858.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products, and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators, and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
About the RTA
The Regenerative Technology Alliance (RTA) a global provider of standards and certification for the emerging fields of regenerative medicine and science, is a 501(c)3 and is supported by donations from individuals, corporations and foundations to help advance its critical mission of bringing peer oversight and transparency to the field of cell-based and regenerative medicine.
For more information visit the RTA website, email david(at)regen-tech(dot)org, or call 503-446-5039.
Excerpt from:
Global Stem Cells Group Announces Alliance with Regenerative Technology
Jeunesse Indonesia ~ Teknologi Stem Cells Resep Awet Muda
Jeunesse #Luminesce See more: http://burinwag.weebly.com/ Register to Jeunesse Global business / Order product, Click here: http://www.burinwag.jeunesseglobal.com/
By: burin junwichai
More here:
Jeunesse Indonesia ~ Teknologi Stem Cells Resep Awet Muda - Video
Allogeneic Stem Cell Transplant | Animation Video
Allogeneic Stem Cell Transplant | Animation Video This video provides extensive details on allogeneic stem cell transplants. A procedure that provides the cancer patient with healthy stem...
By: Medical.Animation.Videos.Library
See more here:
Allogeneic Stem Cell Transplant | Animation Video - Video
Cell Therapy, which is based in the Welsh capital Cardiff, says the medicine has the potential to reduce scarring of the heart muscle caused by a heart attack or failure.
Chief executive Ajan Reginald, who was previously at Roche, said crowd funding was a quick way to raise money for final stage trials or commercial launches.
Loading article content
"It was very fast and very efficient," he said. "We have spent five per cent of our time on fundraising, which enables me to spend 95 per cent of my time on the business."
The company's founder Martin Evans shared the 2007 Nobel Prize for medicine for groundbreaking stem cell research.
Cell Therapy used website Crowdcube to raise nearly three times its original target from more than 300 investors.
Mr Reginald said the backers included investment bankers, hedge fund employees and scientists.
"Crowd funding allows investors to look in detail at a company in their own time," he said, adding that some 10,000 investors had seen the pitch.
The company plans to publish data from clinical trials of the drug, called Heartcel, next month, before final stage trials with a view to a launch in 2016.
See more here:
Biotech firm Cell Therapy claims crowdfunding record with heart drug
DUBLIN, Feb .10, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/7zf9mz/cell_therapy) has announced the addition of Jain PharmaBiotech's new report "Cell Therapy - Technologies, Markets and Companies" to their offering.
This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is replacing the old fashioned bone marrow transplants. Role of cells in drug discovery is also described. Cell therapy is bound to become a part of medical practice.
Stem cells are discussed in detail in one chapter. Some light is thrown on the current controversy of embryonic sources of stem cells and comparison with adult sources. Other sources of stem cells such as the placenta, cord blood and fat removed by liposuction are also discussed. Stem cells can also be genetically modified prior to transplantation.
Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine. Pharmaceutical applications of stem cells including those in drug discovery are also described. Various types of cells used, methods of preparation and culture, encapsulation and genetic engineering of cells are discussed. Sources of cells, both human and animal (xenotransplantation) are discussed. Methods of delivery of cell therapy range from injections to surgical implantation using special devices.
Cell therapy has applications in a large number of disorders. The most important are diseases of the nervous system and cancer which are the topics for separate chapters. Other applications include cardiac disorders (myocardial infarction and heart failure), diabetes mellitus, diseases of bones and joints, genetic disorders, and wounds of the skin and soft tissues.
Regulatory and ethical issues involving cell therapy are important and are discussed. Current political debate on the use of stem cells from embryonic sources (hESCs) is also presented. Safety is an essential consideration of any new therapy and regulations for cell therapy are those for biological preparations.
The cell-based markets was analyzed for 2014, and projected to 2024.The markets are analyzed according to therapeutic categories, technologies and geographical areas. The largest expansion will be in diseases of the central nervous system, cancer and cardiovascular disorders. Skin and soft tissue repair as well as diabetes mellitus will be other major markets.
The number of companies involved in cell therapy has increased remarkably during the past few years. More than 500 companies have been identified to be involved in cell therapy and 294 of these are profiled in part II of the report along with tabulation of 285 alliances. Of these companies, 160 are involved in stem cells. Profiles of 72 academic institutions in the US involved in cell therapy are also included in part II along with their commercial collaborations. The text is supplemented with 61 Tables and 16 Figures. The bibliography contains 1,200 selected references, which are cited in the text.
Key Topics Covered:
Read more here:
Cell Therapy Report 2014-2020 - Technologies, Markets and Companies
Biotechs may be flush with cash, thanks to the ol bullish IPO market and an uptick in venture funding. But startups remainon the lookout for alternative funding models with crowdsourcing front and center.
This makes British biotech startup Cell Therapyparticularly interesting,itjustraised 689,246 or a bit over$1 million to launch a stem cell therapy for heart failure. This is one of the highest life sciences-related crowdfunding efforts topped only by Scanadu, whose handheld consumer diagnostic tool raised $1.6 million in Indiegogo.
Cell Therapy, which was founded by 2007 Nobel Prize winner Martin Evans, raised the funding on thesite Crowdcube exceeding its goal of 250,000 with backing from nearly 300 investors. It ceded a mere 0.39% in equity to the backers thatinclude investment bankers, hedge fund employees and scientists, CEO Ajan Reginald said.
It was very fast and very efficient, Reginaldtold Reuters. We have spent 5 percent of our time on fundraising, which enables me to spend 95 percent of my time on the business.
Crowdfunding is increasingly becoming an option for early stage biotechs that want to sidestep the traditional venture-backed approach. On one hand, its a relatively simple means to raise a large amount of seed capital but on the other, there are many more (potentially irate) investors to answer to when a companys in its nascence.
New York-based Poliwoggs entire premise is on bringing crowdfunding to healthcare with aims to help companies raise fundsfrom accredited investors beyond the seed stage, with rounds ranging from $2 million to $10 million mark.Notably, ithas its own regenerative medicine fund.
Part of the idea here is that people want to invest in the things they care about, but they havent always had the opportunity to invest in them, CEO Greg Simon told MedCity News.Were giving people the opportunity to put their money where their passion is.
Thats all fine and good to have a passion for a cause, but the traditional accredited investor whos enmeshed in a crowdfunding effort may still not understand the intricacies of what it takes to get results or a return in a tricky field like regenerative medicine.
John Carroll over atFierce Biotechopined that crowdfunding wont make a significant dent in the approach to life sciences crowdfunding. Stem cell therapy, after all, generated tons of media pomp and flair a decade ago, but has yet to deliver on many of its curative promises from back then. VCs are often burnt and reticent, and investors on crowdfunding sites will likely be, as well. Carroll says:
Read more here:
Cell Therapy may have just raised $1M, but will crowdfunding have a lasting place in biotech?
Stem cells treatment for chronic pain: What can I expect? (Part 3)
https://plus.google.com/+ColumbiaPainManagementPCHoodRiver/ (541) 716-6469 What can I expect if I have stem cell treatment for chronic pain due to arthritis? Doctors at Columbia Pain ...
By: Trey Rigert
Read more:
Stem cells treatment for chronic pain: What can I expect? (Part 3) - Video
FAQ Part 4: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS)
The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation have announced a $4.2 million grant in support of the MEsenchymal Stem cell therapy for CAnadian.
By: MSSocietyCanada
View post:
FAQ Part 4: MEsenchymal Stem cell therapy for CAnadian MS patients (MESCAMS) - Video
The Human Genome Unlocked
The Aspen Health Forum, 2009. With the mapping of the human genome complete, scientists are hoping to use stem cell therapy and related interventions to alleviate or even cure diseases. What...
By: The Aspen Institute
Read this article:
The Human Genome Unlocked - Video
Luminesce (Jeunesse) -The State Of the Art Product. Stem Cells. Dr. Newman
This is the 1st Introduction Video in Your Discovery for our Miracle Products. Innovation in Anti Aging Technology. Stop aging process Join us on https://www.facebook.com/JeunesseDubai?ref=hli.
By: Jeunesse Dubai
Read more:
Luminesce (Jeunesse) -The State Of the Art Product. Stem Cells. Dr. Newman - Video
STEM CELLS EMBRYOS: ABC Lateline: Alan Trounson David van Gend - 14/8/2002
ABC TV LATELINE "Stem cells: science and ethics clash" - 14/8/2002 TRANSCRIPT at http://www.abc.net.au/lateline/stories/s649062.htm A debate just prior to th...
By: David van Gend
Read more:
STEM CELLS & EMBRYOS: ABC Lateline: Alan Trounson & David van Gend - 14/8/2002 - Video
Towards Innovative New Approaches to Therapies
Bruce Torbett of The Scripps Research Institute (TSRI), develops innovative approaches for gene and stem cell therapy that could lead to more effective treat...
By: Scripps Research Institute
See the original post:
Towards Innovative New Approaches to Therapies - Video